Search

Search Results
Results 1 - 10 of 96 for Diabetes Type II
  • Drug - 1 Aug 2022
    Consumer Medicine Information (CMI) about Glyade (Immediate release tablets containing gliclazide) intended for persons living in Australia.
  • Drug - 30 Apr 2024
    Consumer Medicine Information (CMI) about Trajentamet (linagliptin / metformin hydrochloride) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Gliclazide MR Viatris (containing gliclazide) intended for persons living in Australia.
  • Drug - 21 Sep 2022
    Consumer Medicine Information (CMI) about Jardiamet (empagliflozin / metformin hydrochloride) intended for persons living in Australia.
  • Drug - 1 Aug 2022
    Consumer Medicine Information (CMI) about Glyade MR (containing gliclazide) intended for persons living in Australia.
  • Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Diamicron 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Drug - 18 Jul 2022
    Consumer Medicine Information (CMI) about Ardix Gliclazide 60mg MR (containing gliclazide) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Glucovance intended for persons living in Australia.
  • Drug - 24 Mar 2023
    Consumer Medicine Information (CMI) about Abisart intended for persons living in Australia.
  • Drug - 13 Dec 2022
    Consumer Medicine Information (CMI) about Adesan HCT intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.